These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 6060734

  • 21. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
    Komarov AL, Panchenko EP, Eshkeeva AR, Dobrovol'skiĭ AB, Titaeva EV, Karpov IuA.
    Ter Arkh; 1996 May 23; 68(2):49-53. PubMed ID: 8771659
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B, Gormsen J.
    Scand J Haematol; 1969 May 23; 6(6):402-8. PubMed ID: 5374117
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The efficacy of ticlid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities].
    Kirichenko AA, Prekina VI, Repinskaia NP, Novichkova IuN, Ter-Gevondian NM, Vinogradova IV.
    Ter Arkh; 1994 May 23; 66(12):23-6. PubMed ID: 7900036
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E.
    G Gerontol; 1967 Dec 23; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract] [Full Text] [Related]

  • 36. [Physical and exercise therapy of chronic obliterating arteriopathy of the lower limbs: clinical study].
    Galante M, Franchignoni F, Andina A, Grioni G.
    Clin Ter; 1982 May 31; 101(4):357-62. PubMed ID: 7105641
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases].
    Belcaro G, Cesarone MR, Bucci M, Iacobitti P, Dugall M.
    Minerva Cardioangiol; 1998 Oct 31; 46(10 Suppl 1):55-8. PubMed ID: 10658446
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.